BlackRock’s TuHURA Biosciences HURA Stock Holding History

BlackRock’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.39M	Buy	2,450,256 +883,892	+56%	+$1.08M	﹤0.01%	3880
2025 Q4	$1.19M	Buy	1,566,364 +44,410	+3%	+$85K	﹤0.01%	4263
2025 Q3	$3.77M	Buy	1,521,954 +183,728	+14%	+$484K	﹤0.01%	3897
2025 Q2	$2.98M	Buy	1,338,226 +964,029	+258%	+$3.26M	﹤0.01%	3949
2025 Q1	$1.21M	Sell	374,197 -17,110	-4%	-$63.2K	﹤0.01%	4140
2024 Q4	$1.6M	Buy	+391,307	New	+$2.08M	﹤0.01%	4096
2022 Q2	–	Sell	-52	Closed	-$36K	–	6020
2022 Q1	$36K	Sell	52 -3	-5%	-$2.16K	﹤0.01%	5481
2021 Q4	$49K	Buy	55 +13	+31%	+$17.6K	﹤0.01%	5404
2021 Q3	$64K	Sell	42 -1	-2%	-$2.63K	﹤0.01%	5244
2021 Q2	$172K	Buy	+43	New	+$124K	﹤0.01%	4928

Other funds holding HURA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

BlackRock's HURA Position: Q1 2026 in Review

BlackRock increased its TuHURA Biosciences (HURA) stake by 56% in Q1 2026, buying an estimated $1.08M and bringing the position to 2,450,256 shares worth $4.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3880.

BlackRock first reported a position in HURA in Q2 2021 and has held it in 10 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

BlackRock held 2,450,256 shares of TuHURA Biosciences worth $4.39M as of Q1 2026.
BlackRock bought 883,892 TuHURA Biosciences shares in Q1 2026, an estimated $1.08M.
TuHURA Biosciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3880 holding.
BlackRock first reported a position in TuHURA Biosciences in Q2 2021 and has held it in 10 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.